408 related articles for article (PubMed ID: 33560148)
1. MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease.
Qin X; Zhang X; Li P; Wang M; Yan L; Pan P; Zhang H; Hong X; Liu M; Bao Z
J Drug Target; 2021 Sep; 29(8):875-883. PubMed ID: 33560148
[TBL] [Abstract][Full Text] [Related]
2. Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease.
Liu YY; Zhang YN; Yang QS
J Cell Physiol; 2018 Nov; 233(11):8617-8629. PubMed ID: 29761857
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway.
Cai L; Tu L; Li T; Yang X; Ren Y; Gu R; Zhang Q; Yao H; Qu X; Wang Q; Tian J
Int Immunopharmacol; 2019 Oct; 75():105734. PubMed ID: 31301558
[TBL] [Abstract][Full Text] [Related]
4. Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson's disease rats via regulation of TLR/NF-κB signaling pathway.
Ma X; Wang Y; Yin H; Hua L; Zhang X; Xiao J; Yuan Q; Wang S; Liu Y; Zhang S; Wang Y
Brain Res Bull; 2021 Sep; 174():22-30. PubMed ID: 33933526
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of lncRNA BACE1-AS improves dopamine-dependent oxidative stress in rats with Parkinson's disease by upregulating microRNA-34b-5p and downregulating BACE1.
Li Y; Fang J; Zhou Z; Zhou Q; Sun S; Jin Z; Xi Z; Wei J
Cell Cycle; 2020 May; 19(10):1158-1171. PubMed ID: 32308102
[No Abstract] [Full Text] [Related]
6. Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation.
Peng T; Liu X; Wang J; Liu Y; Fu Z; Ma X; Li J; Sun G; Ji Y; Lu J; Wan W; Lu H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2764-2774. PubMed ID: 31298038
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson's disease via suppression of LASP1.
Ma X; Zhang H; Yin H; Geng S; Liu Y; Liu C; Zhao J; Liu Y; Wang X; Wang Y
Brain Res Bull; 2021 Jan; 166():92-101. PubMed ID: 33144090
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1.
Cai LJ; Tu L; Li T; Yang XL; Ren YP; Gu R; Zhang Q; Yao H; Qu X; Wang Q; Tian JY
Aging (Albany NY); 2020 Jan; 12(1):672-689. PubMed ID: 31927536
[TBL] [Abstract][Full Text] [Related]
9. miR-186-3p attenuates the tumorigenesis of cervical cancer via targeting insulin-like growth factor 1 to suppress PI3K-Akt signaling pathway.
Lu X; Song X; Hao X; Liu X; Zhang X; Yuan N; Ma H; Zhang Z
Bioengineered; 2021 Dec; 12(1):7079-7092. PubMed ID: 34551673
[TBL] [Abstract][Full Text] [Related]
10. Effects of microRNA-206 and its target gene IGF-1 on sevoflurane-induced activation of hippocampal astrocytes in aged rats through the PI3K/AKT/CREB signaling pathway.
Liu TJ; Wang B; Li QX; Dong XL; Han XL; Zhang SB
J Cell Physiol; 2018 May; 233(5):4294-4306. PubMed ID: 29052839
[TBL] [Abstract][Full Text] [Related]
11. microRNA-206 is required for osteoarthritis development through its effect on apoptosis and autophagy of articular chondrocytes via modulating the phosphoinositide 3-kinase/protein kinase B-mTOR pathway by targeting insulin-like growth factor-1.
Yu Q; Zhao B; He Q; Zhang Y; Peng XB
J Cell Biochem; 2019 Apr; 120(4):5287-5303. PubMed ID: 30335903
[TBL] [Abstract][Full Text] [Related]
12. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
Jiang Z; Wang J; Sun G; Feng M
Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway.
Huang N; Zhang Y; Chen M; Jin H; Nie J; Luo Y; Zhou S; Shi J; Jin F
Exp Gerontol; 2019 Sep; 124():110653. PubMed ID: 31295526
[TBL] [Abstract][Full Text] [Related]
14. Squamosamide derivative FLZ protected dopaminergic neuron by activating Akt signaling pathway in 6-OHDA-induced in vivo and in vitro Parkinson's disease models.
Bao XQ; Kong XC; Kong LB; Wu LY; Sun H; Zhang D
Brain Res; 2014 Feb; 1547():49-57. PubMed ID: 24384139
[TBL] [Abstract][Full Text] [Related]
15. [Effect of electroacupuncture on GLP-1R/PI3K/Akt protein pathway in mice with Parkinson's disease].
Li HZ; Qi L; Zhang XL; Chen XL; Guo L; Guo SQ; Ma J
Zhen Ci Yan Jiu; 2022 Jan; 47(1):27-32. PubMed ID: 35128867
[TBL] [Abstract][Full Text] [Related]
16. Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson's disease.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Lu J; Chen GQ; Zheng YL
J Cell Physiol; 2019 Jun; 234(6):9033-9044. PubMed ID: 30362546
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of miR-365 promotes the apoptosis and restrains proliferation of synoviocytes through downregulation of IGF1 and the inactivation of the PI3K/AKT/mTOR pathway in mice with rheumatoid arthritis.
Wang X; Gong S; Pu D; Hu N; Wang Y; Fan P; Zhang J; Lu X
Int Immunopharmacol; 2020 Feb; 79():106067. PubMed ID: 31881377
[TBL] [Abstract][Full Text] [Related]
18. Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease.
Dong Y; Han LL; Xu ZX
Mol Med; 2018 Nov; 24(1):61. PubMed ID: 30486773
[TBL] [Abstract][Full Text] [Related]
19. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
Zhou S; Zhou X; Jiang Z; Ma J; Li Y; Qian Z; Li H
Neurochem Res; 2023 Mar; 48(3):942-955. PubMed ID: 36401052
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
Wang L; Liu WX; Huang XG
Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
